INGREZZA - For the treatment of chorea associated with Huntington's Disease (HD) TOOLKIT & RESOURCESkatrina4384Sep 26, 20231 min readFind out more here:INGREZZA HDC Launch Toolkit_FINAL.pdf
Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington's Disease
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease
Comments